In an earlier study, we described the presence of a retroendocytotic pathway for insulin in a cultured kidney epithelial cell line. Derived from the opossum kidney (OK), these cells possess many features of proximal tubule epithelium, which is the major site of kidney insulin metabolism. We studied the interaction between the retroendocytotic and the degradative pathways with bacitracin as a pharmacological probe. Monolayers of OK cells were loaded with 125I-labeled insulin over 30 min, acid washed to remove membrane-bound insulin, then incubated in fresh medium for 60 min while the release of intracellular radioactivity was monitored. In experiments carried out in the presence of bacitracin (2 mM), there was a twothirds increase in intracellular radioactivity at the end of the loading phase. Measurements made during the subsequent release phase showed that bacitracin reduced the release of degradation products. Thus, although controls released 72.1 ± 8.1% of the internalized radioactivity as trichloroacetic acid (TCA)-soluble products, bacitracin-treated cells released 59.2 ± 9.4% (P < 0.02). In contrast, release of TCAprecipitable insulin increased from 15.2 ± 4.6% in controls to 25.8 ± 3.7% in bacitracin-treated cells (P < 0.01). In separate experiments analyzed by gelexclusion chromatography, 6.4 ± 0.6% of radioactivity released from preloaded control cells into medium over 60 min was insulin sized compared to 29.7 ± 1.4% in bacitracin-treated cells. High-performance liquid chromotography revealed that 61.5 ± 3.5% of this insulin-sized material released from control cells preloaded with A14-insulin eluted as intact insulin and the remainder as unidentified intermediate degradation products. In the bacitracin group, 48.0 ± 2.1% of the radioactivity eluted with insulin, and 18.5 ± 0.6% eluted under a series of peaks representing intermediate products. Included in this material was a doublet, which has been identified in previous experiments with OK cells, other cell types, and liver endosomes. Previous characterization of this doublet indicates that it results from cleavage of insulin by insulin protease or a similar enzyme. We conclude that, by inhibiting the initial steps in the degradation of insulin, bacitracin diverts intact insulin and early degradation products from the degradative to the retroendocytotic pathway. These findings suggest that insulin degradation commences in an extralysosomal site, probably recycling endosomes.
Skip Nav Destination
Article navigation
Original Articles|
November 01 1990
Effect of Bacitracin on Retroendocytosis and Degradation of Insulin in Cultured Kidney Epithelial Cell Line
David C Dahl;
David C Dahl
Department of Medicine, Stanford University
Stanford
Veterans Administration Medical Center
Palo Alto, California
Veterans Administration Medical Center and University of Nebraska Medical Center
Omaha, Nebraska
Eli Lilly Research Laboratories, Eli Lilly and Company
Indianapolis, Indiana
Search for other works by this author on:
Tanny Tsao;
Tanny Tsao
Department of Medicine, Stanford University
Stanford
Veterans Administration Medical Center
Palo Alto, California
Veterans Administration Medical Center and University of Nebraska Medical Center
Omaha, Nebraska
Eli Lilly Research Laboratories, Eli Lilly and Company
Indianapolis, Indiana
Search for other works by this author on:
William C Duckworth;
William C Duckworth
Department of Medicine, Stanford University
Stanford
Veterans Administration Medical Center
Palo Alto, California
Veterans Administration Medical Center and University of Nebraska Medical Center
Omaha, Nebraska
Eli Lilly Research Laboratories, Eli Lilly and Company
Indianapolis, Indiana
Search for other works by this author on:
Bruce H Frank;
Bruce H Frank
Department of Medicine, Stanford University
Stanford
Veterans Administration Medical Center
Palo Alto, California
Veterans Administration Medical Center and University of Nebraska Medical Center
Omaha, Nebraska
Eli Lilly Research Laboratories, Eli Lilly and Company
Indianapolis, Indiana
Search for other works by this author on:
Ralph Rabkin
Ralph Rabkin
Department of Medicine, Stanford University
Stanford
Veterans Administration Medical Center
Palo Alto, California
Veterans Administration Medical Center and University of Nebraska Medical Center
Omaha, Nebraska
Eli Lilly Research Laboratories, Eli Lilly and Company
Indianapolis, Indiana
Search for other works by this author on:
Address correspondence and reprint requests to Ralph Rabkin, MD, Veterans Administration Medical Center (111R), 3801 Miranda Avenue, Palo Alto, CA 94304.
Diabetes 1990;39(11):1339–1346
Article history
Received:
July 20 1989
Revision Received:
June 21 1990
Accepted:
June 21 1990
PubMed:
2227108
Citation
David C Dahl, Tanny Tsao, William C Duckworth, Bruce H Frank, Ralph Rabkin; Effect of Bacitracin on Retroendocytosis and Degradation of Insulin in Cultured Kidney Epithelial Cell Line. Diabetes 1 November 1990; 39 (11): 1339–1346. https://doi.org/10.2337/diab.39.11.1339
Download citation file:
25
Views